Laman UtamaKVUE • NYSE
add
Kenvue Inc
$14.11
Selepas Waktu Dagangan:(0.28%)+0.040
$14.15
Tutup: 16 Okt, 7:59:23 PTG GMT-4 · USD · NYSE · Penafian
youtube_trendingSohor Kinitrending_downPenurunan terbesarequalizerPaling aktifSahamSekuriti tersenarai ASIbu pejabat di AS
Tutup sebelumnya
$16.26
Julat hari
$14.05 - $16.43
Julat tahun
$14.05 - $25.17
Permodalan pasaran
27.08B USD
Bilangan Purata
38.16J
Nisbah P/E
19.17
Hasil dividen
5.88%
Pertukaran utama
NYSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Hasil | 3.84B | -4.02% |
Perbelanjaan pengendalian | 1.51B | -8.78% |
Pendapatan bersih | 420.00J | 624.14% |
Margin untung bersih | 10.94 | 654.48% |
Pendapatan bagi setiap syer | 0.29 | -9.38% |
EBITDA | 902.00J | 4.52% |
Kadar cukai berkesan | 28.57% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 1.07B | 5.52% |
Jumlah aset | 27.13B | 2.61% |
Jumlah liabiliti | 16.40B | 0.84% |
Jumlah ekuiti | 10.73B | — |
Syer tertunggak | 1.92B | — |
Harga kepada buku | 2.91 | — |
Pulangan pada aset | 7.12% | — |
Pulangan pada modal | 9.90% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Jun 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 420.00J | 624.14% |
Tunai daripada operasi | 621.00J | 41.14% |
Tunai daripada pelaburan | -90.00J | -5.88% |
Tunai daripada pembiayaan | -548.00J | -11.84% |
Perubahan bersih dalam tunai | 13.00J | 109.22% |
Aliran tunai bebas | 565.12J | 27.86% |
Perihal
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
Kenvue employed about 22,200 people in 2022 and was first led by CEO Thibaut Mongon. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Diasaskan
23 Feb 2022
Ibu pejabat
Tapak web
Pekerja
22,000